Ingram Screening Collaborative Set for 2024

January 8, 2024 7:30 am - 9:00 am PST

April 8, 2024 7:30 am - 9:00 am PST

July 8, 2024 7:30 am - 9:00 am PST

October 7, 2024 7:30 am - 9:00 am PST

Establish Goals and Objectives:

• Define the goals and objectives of the collaborative, such as increasing awareness, improving screening protocols, and enhancing support services for individuals at risk of PMADs.

Cultural Competence and Inclusivity:

• Ensure that the collaborative is culturally competent and inclusive, recognizing the unique needs and experiences of diverse populations (who do we need to invite?)

Needs Assessment:

• Identify the local or regional needs for PMAD screening and support. This may involve reviewing existing data on PMAD prevalence, healthcare infrastructure, and available resources.

Appreciative Inquiry Method: 

• What is it and what does it look like in practice?

Screening Protocols:

• Develop or adopt evidence-based screening protocols for PMADs. These should be integrated into routine prenatal and postpartum care.

Data Collection and Monitoring:

• Implement a system for collecting data on PMAD screening and outcomes. Regularly monitor and evaluate the effectiveness of the screening program.

Referral and Treatment Pathways:

• Establish clear referral pathways for individuals who screen positive for PMADs to receive appropriate treatment and support services.

Resource Allocation:

• Identify and allocate resources, including funding, staff, and technology, to support the collaborative's activities.

Outreach and Networking:

• Reach out to other organizations and professionals who can contribute to the collaborative's mission, such as obstetricians, pediatricians, and mental health providers.

Sustainability:

• Develop a plan for the long-term sustainability of the collaborative, including strategies for adding members and increasing support across disciplines.

Legal and Ethical Considerations:

• Address legal and ethical issues related to PMAD screening, data privacy, and informed consent.

Community Engagement:

• Engage with the community to gather feedback, build trust, and ensure that the collaborative's efforts align with the needs and preferences of the community.

Documentation and Reporting:

• Maintain clear and comprehensive documentation of collaborative activities, outcomes, and impact, which may be required for reporting to funders or stakeholders.

Public Awareness Campaigns:

• Develop public awareness campaigns to reduce stigma and increase awareness of PMADs. These campaigns can help individuals recognize the symptoms and seek help.

Evaluation and Improvement:

• Regularly assess the collaborative's performance and make necessary improvements to enhance the quality and impact of the PMAD screening and support efforts.